Información*
| Nombre | EMA ELVIRA HERRERA LOPEZ |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MEDICAS |
| Disciplina | FARMACOLOGÍA |
| Especialidad | FARMACOLOGIA MOLECULAR |
| CVU | 896559 |
| Institución | |
|---|---|
| Dependencia | DIVISION MEDICA |
| Entidad | CIUDAD DE MEXICO |
| Nivel | C |
| Vigencia | Inicio: 01/01/2026 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- ARE PROSTATE CANCER RISK CALCULATORS VALID FOR THE MEXICAN POPULATION? JOURNAL OF UROLOGY
- 2025
- Phase angle as a prognostic factor of survival in patients with metastatic prostate cancer CLINICAL NUTRITION ESPEN
- 2024
- Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma HEPATOMA RESEARCH
- Intriguing hepatoprotective effects of sucrose on hepatocellular carcinoma pathogenesis SCIENTIFIC REPORTS
- 2023
- Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis SCIENTIFIC REPORTS
- 2019
- Association of rs2000999 in the haptoglobin gene with total cholesterol, HDL-C, and LDL-C levels in Mexican type 2 diabetes patients MEDICINE
- 2018
- The rs1256031 of estrogen receptor β gene is associated with type 2 diabetes DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS
